IMR Press / FBL / Volume 13 / Issue 10 / DOI: 10.2741/2969

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article

The Epstein-Barr virus (EBV) protein EB2 is an mRNA export factor essential for virus production

Show Less
1 INSERM U758, 46 allee d’Italie, 69364 Lyon Cedex 07, France
2 ENSLyon, 46 allee d’Italie, 69364 Lyon Cedex 07, France
3 IFR 128 BioSciences Gerland-Lyon Sud, 21 avenue Tony Garnier, 69365, Lyon Cedex 07, France

*Author to whom correspondence should be addressed.

Academic Editor: Zhi-Ming Zheng

Front. Biosci. (Landmark Ed) 2008, 13(10), 3798–3813; https://doi.org/10.2741/2969
Published: 1 May 2008
(This article belongs to the Special Issue Protein-RNA interactions in viral RNA processing)
Abstract

The EBV early protein EB2 (aka Mta, SM and BMLF1) shares properties with mRNA export factors. It shuttles between the cytoplasm and the nucleus, and interacts with RNA both in vitro and in vivo but with no apparent sequence specificity. EB2 induces the cytoplasmic accumulation of mRNAs generated from intronless and intron-containing genes, likely through interactions with cellular export factors of the TAP/p15 pathway. Using a cell line carrying a viral genome with the EB2 gene deleted, it has been shown that EB2 is essential for the production of infectious virions by facilitating the nuclear export of a subset of early and late viral mRNAs, a function regulated by CK2 phosphorylation of EB2. There are docking sites for both CK2 subunits and for the heterotetrameric enzyme in the EB2 N- and C-terminal domains. Accordingly, EB2 and CK2 co-purify as a complex in which CK2 phosphorylates EB2. CK2 phosphorylation of EB2 at one of the Ser-55, Ser-56 and ser-57 is critical for its mRNA export function and as a consequence, for infectious virus production.

Share
Back to top